Invitation to first half results 2023 presentation of EXACT Therapeutics AS

 EXACT Therapeutics AS will release the interim first half 2023 results on Thursday 28 September 2023 at 08:00 (CEST).

A presentation of the first half year 2023 financials followed by a Q&A session will be held on the same day 14:00-15:00 at Carnegie's offices at Aker Brygge, Fjordalleen 16, and through a live webcast. The company expects to have the top line clinical results of the dose-escalation study available and released by this date, which will be included in the presentation. The presentation and the Q&A session can be followed through a live webcast (Teams) or by physical attendance.

CEO, Per Walday, CFO, John M. Edminson and CMO, Amir Snapir will hold the presentation.

Participants who want to participate in the live webcast or by physical attendance are asked to send an email to john.edminson@exact-tx.com for a separate invitation, which will be distributed 1 day prior to the meeting. It will be possible to post or ask questions throughout the presentation.

The report for the first half year 2023 will be available on www.newsweb.no and on the company's homepage www.exact-tx.com from 08:00 on Thursday, 28 September 2023.